Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P62136
UPID:
PP1A_HUMAN
Alternative names:
-
Alternative UPACC:
P62136; A6NNR3; B2R908; P08129; P20653; P22802; Q07161
Background:
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit plays a pivotal role in various cellular processes, including cell division, glycogen metabolism, muscle contractility, and protein synthesis. It is a key regulator of ionic conductances and synaptic plasticity, essential for neural development and function. Its involvement in chromatin structure regulation and cell cycle progression highlights its importance in cellular integrity and division.
Therapeutic significance:
Understanding the role of Serine/threonine-protein phosphatase PP1-alpha catalytic subunit could open doors to potential therapeutic strategies. Its critical function in cell division and regulation of neural development positions it as a potential target in treating diseases related to cell proliferation and neural disorders.